U.S. National Institute of Health www.cancer.gov National Cancer Institute
National Cancer Institute
NCI Alliance for Nanotechnology in Cancer

About Programs News Resources Events Intranet Login
National Cancer Institute


NCI Alliance for
Nanotechnology in Cancer


Mission & Goals
Cancer Nanotechnology
Plan
Cancer Nanotechnology
Working Groups
Areas of Focus
Questions and Answers
Integration
Fact Sheets
Bios

 

Cancer Nanotechnology Working Group (CNWG)

Helping guide the programmatic activities of the NCI Alliance for Nanotechnology in Cancer is the Cancer Nanotechnology Working Group (CNWG), which was formed from the Cancer Nanotechnology Intramural Working Group and the Cancer Nanotechnology Extramural Intramural Working Group. The CNWG has a tracking function and continues (as the two subgroups have in the past) to act in an advisory capacity as the Cancer Nanotechnology Plan moves forward.

The CNWG played a key role in coordinating multiple Cancer Nanotechnology Symposia held at regional cancer and advanced technology centers. Subsequently, group members helped to plan the NCI-sponsored intramural Nanotechnology Seminar Series which began in January 2005.


CNWG Members

   

Bill Allaben (FDA)

Neil Goldman

Paul Nisson

Anna Barker

David Goldstein

Chip Petricoin (FDA)

Ken Buetow

Jorge Gomez

Nakissa Sadrieh (FDA)

Martin Brechbiel

Peter Greenwald

Jeff Schloss (NHGRI)

Mike Buck

Angela High Walker (NIST)

Shoshana Segal

Philip Castle

Paul Howard (FDA)

Daniela Seminara

Peter Choyke

Steve Libutti

Sudhir Srivastava

Greg Downing

Lance Liotta

Lisa Stevens

Travis Earles

Ellen Miller

Dan Sullivan

David Eckstein

Jim Mitchell

Michael Tangrea

Mauro Ferrari

Ed Monachino

Kirt Vener

Dan Gallahan

Satoshi Nishizuka

Kathy Zoon


*unless otherwise noted, CNWG members from NCI



A Service of the National Cancer Institute
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov Nanotechnology Characterization Lab Nanotechnology Teaming Portal